Wenxiu Han1, Chunxiang Zhang2, Hui Wang3, Mengqi Yang1, Yujin Guo1, Gongying Li4, Hailiang Zhang1, Changshui Wang1, Dan Chen1, Chunmei Geng1, Pei Jiang1. 1. Institute of Clinical Pharmacy & Pharmacology, Jining First People's Hospital, Jining Medical University, Jining 272011, China. 2. Department of Cardiology, Jining First People's Hospital, Jining Medical University, Jining 272011, China. 3. Department of Gynecology, Jinxiang People's Hospital, Jining 272200, China. 4. Department of Mental Health, Jining Medical University, Jining 272000, China.
Abstract
BACKGROUND: Depression is a well-known co-morbidity of coronary heart disease (CHD) and these two diseases share common risk mechanisms. Here, the aim of this study was to investigate the possible link between energy homeostasis regulation and CHD patients comorbid with depression. METHODS: Two hundred and nine CHD patients and 101 matched healthy individuals were included. Demographic, clinical data were collected, serum irisin, adropin, preptin and brain-derived neurotrophic factor (BDNF) levels were determined by a double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA), and the depression was scored by Patient Health Questionnaire-9 (PHQ-9). Correlation analysis as well as multiple linear regression was used to assess the relationship between the three peptides, BDNF serum levels and PHQ-9 scores. RESULTS: Irisin serum level was significantly lower in CHD patients without depression as compared with healthy controls (P=0.002), as well as adropin (P=0.000), preptin (P=0.000) and BDNF (P=0.000). Furthermore, similar trends were observed in CHD patients with depression in terms of irisin, adropin and BDNF as compared with CHD patients without depression (P=0.006; P=0.003; P=0.002; respectively). Multiple logistic regression results confirmed the contribution of irisin and BDNF to the occurrence of depression in CHD. Interestingly, correlations analysis revealed significant negative correlations between PHQ-9 scores and irisin, adropin, BDNF level (r=-0.43, P<0.01; r=-0.29, P<0.05; r=-0.45, P<0.001 respectively), and irisin serum level was positively correlated with BDNF (r=0.38, P<0.01). CONCLUSIONS: Our study firstly identified the role of energy homeostasis in the susceptibility to depression in CHD patients, and the interaction between irisin and BDNF could trigger the imbalance of energy homeostasis that occurs in depression of CHD patients.
BACKGROUND: Depression is a well-known co-morbidity of coronary heart disease (CHD) and these two diseases share common risk mechanisms. Here, the aim of this study was to investigate the possible link between energy homeostasis regulation and CHD patients comorbid with depression. METHODS: Two hundred and nine CHD patients and 101 matched healthy individuals were included. Demographic, clinical data were collected, serum irisin, adropin, preptin and brain-derived neurotrophic factor (BDNF) levels were determined by a double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA), and the depression was scored by Patient Health Questionnaire-9 (PHQ-9). Correlation analysis as well as multiple linear regression was used to assess the relationship between the three peptides, BDNF serum levels and PHQ-9 scores. RESULTS: Irisin serum level was significantly lower in CHD patients without depression as compared with healthy controls (P=0.002), as well as adropin (P=0.000), preptin (P=0.000) and BDNF (P=0.000). Furthermore, similar trends were observed in CHD patients with depression in terms of irisin, adropin and BDNF as compared with CHD patients without depression (P=0.006; P=0.003; P=0.002; respectively). Multiple logistic regression results confirmed the contribution of irisin and BDNF to the occurrence of depression in CHD. Interestingly, correlations analysis revealed significant negative correlations between PHQ-9 scores and irisin, adropin, BDNF level (r=-0.43, P<0.01; r=-0.29, P<0.05; r=-0.45, P<0.001 respectively), and irisin serum level was positively correlated with BDNF (r=0.38, P<0.01). CONCLUSIONS: Our study firstly identified the role of energy homeostasis in the susceptibility to depression in CHD patients, and the interaction between irisin and BDNF could trigger the imbalance of energy homeostasis that occurs in depression of CHD patients.
Authors: Thomas Rutledge; Veronica A Reis; Sarah E Linke; Barry H Greenberg; Paul J Mills Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094
Authors: Fina Lovren; Yi Pan; Adrian Quan; Krishna K Singh; Praphulla C Shukla; Milan Gupta; Mohammed Al-Omran; Hwee Teoh; Subodh Verma Journal: Circulation Date: 2010-09-14 Impact factor: 29.690
Authors: K Ganesh Kumar; James L Trevaskis; Daniel D Lam; Gregory M Sutton; Robert A Koza; Vladimir N Chouljenko; Konstantin G Kousoulas; Pamela M Rogers; Robert A Kesterson; Marie Thearle; Anthony W Ferrante; Randall L Mynatt; Thomas P Burris; Jesse Z Dong; Heather A Halem; Michael D Culler; Lora K Heisler; Jacqueline M Stephens; Andrew A Butler Journal: Cell Metab Date: 2008-12 Impact factor: 27.287
Authors: Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley Journal: JAMA Date: 2003-07-09 Impact factor: 56.272
Authors: Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman Journal: Nature Date: 2012-01-11 Impact factor: 49.962
Authors: Mariami Jasaszwili; Maria Billert; Mathias Z Strowski; Krzysztof W Nowak; Marek Skrzypski Journal: Molecules Date: 2020-01-27 Impact factor: 4.411
Authors: Patrick Mucher; Delgerdalai Batmyagmar; Thomas Perkmann; Manuela Repl; Astrid Radakovics; Elisabeth Ponocny-Seliger; Ina Lukas; Monika Fritzer-Szekeres; Johann Lehrner; Thomas Knogler; Dimiter Tscholakoff; Martina Fondi; Oswald F Wagner; Robert Winker; Helmuth Haslacher Journal: Psychophysiology Date: 2021-03-02 Impact factor: 4.016
Authors: Elke Albrecht; Lisa Schering; Friedrich Buck; Konrad Vlach; Hans-Christof Schober; Christian A Drevon; Steffen Maak Journal: Mol Metab Date: 2020-01-31 Impact factor: 7.422